Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive methylprednisolone with or without gabapentin for pain control after total knee arthroplasty in elderly patients
IRCT20190325043107N64Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methylprednisolone and gabapentin in postoperative pain (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Postoperative pain. Started Jun 2024; status: completed.
02
Drugs
methylprednisolonegabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190325043107N64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N64.